• Special Issue Topic

    Recent Advances in Hypertension

    Submission Deadline: June 30, 2022

    Guest Editor

    Prof. Simon W. Rabkin E-Mail

    Professor of Medicine, University of British Columbia; Cardiology Staff, Vancouver Hospital, Vancouver, Canada

    About the Special Issue

    Hypertension remains an important factor leading to many conditions including heart failure, chronic kidney disease, stroke, aortic aneurysms and dementia. The objective of this volume is to focus on areas that have advanced our knowledge and will guide clinicians and scientists to future advances in the field. The contributions in this issue should improve our knowledge on the detection/diagnosis of hypertension and its consequences, improve our understanding of the pathophysiologic linkages in hypertension and guide us to better prevention, management and control in order to lessen the burden of hypertension associated diseases. There’s still much to learn about how hypertension leads to its devastating effects on the heart, kidney, arteries, brain and other organs. This issue will be inclusive and encompass all important areas of recent advances spanned the range from genetics, epigenetics, immunology, micro RNA, vascular and organ structural changes, signal transduction pathways, neurohormonal activation and inhibition, as well as clinical advances and insights. Advances in potential therapeutic areas will also be included. This issue on Recent Advances in Hypertension will be a summary of recent advances in the field and also will be a guide for clinicians and scientists on how we should proceed to better control or eliminate hypertension and its adverse consequences. non-coding RNA, gut microbiota, ageing, uremic toxins, biological activity, medical use, pharmacological interactions.

    Special Issue Flyer.pdf

    Call for Papers

    Published Articles

    Open Access
    Assessing cardiac contractility in hypertension with heart failure with preserved ejection fraction: the value of left ventricular strain
    Aim: Hypertension (HTN) is a major cause of heart failure but the precise pathways by which HTN leads to heart failure are not resolved. Newer echocardiographic techniques permit assessment of my [...] Read more.
    Simon W. Rabkin
    Published: April 10, 2023 Explor Med. 2023;4:115–126
    DOI: https://doi.org/10.37349/emed.2023.00128
    Times Cited: 0
    Open Access
    Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease
    Current evidence on benefits of night-time blood pressure (BP) lowering drug treatment on cardiovascular disease (CVD) prevention attributable to the Ambulatory Blood Pressure Monitoring in the Pred [...] Read more.
    Chau Le Bao Ho, Christopher M. Reid
    Published: October 27, 2022 Explor Med. 2022;3:461–467
    DOI: https://doi.org/10.37349/emed.2022.00107
    Open Access
    Vasopressin: a possible link between hypoxia and hypertension
    Cardiovascular and respiratory diseases are frequently associated with transient and prolonged hypoxia, whereas hypoxia exerts pro-hypertensive effects, through stimulation of the sympathetic system [...] Read more.
    Ewa Szczepańska-Sadowska, Tymoteusz Żera
    Published: October 11, 2022 Explor Med. 2022;3:414–431
    DOI: https://doi.org/10.37349/emed.2022.00103
    Times Cited: 0